Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

GE HealthCare Technologies (GEHC) EBIAT (2022 - 2025)

GE HealthCare Technologies' EBIAT history spans 4 years, with the latest figure at $602.0 million for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT fell 22.62% year-over-year to $602.0 million, compared with a TTM value of $2.1 billion through Dec 2025, up 1.98%, and an annual FY2025 reading of $2.2 billion, up 5.07% over the prior year.
  • EBIAT for Q4 2025 was $602.0 million at GE HealthCare Technologies, up from $446.0 million in the prior quarter.
  • The five-year high for EBIAT was $778.0 million in Q4 2024, with the low at $366.0 million in Q4 2023.
  • Average EBIAT over 4 years is $477.9 million, with a median of $458.0 million recorded in 2024.
  • Year-over-year, EBIAT tumbled 31.46% in 2023 and then soared 112.57% in 2024.
  • Tracing GEHC's EBIAT over 4 years: stood at $534.0 million in 2022, then tumbled by 31.46% to $366.0 million in 2023, then soared by 112.57% to $778.0 million in 2024, then fell by 22.62% to $602.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's EBIAT are $602.0 million (Q4 2025), $446.0 million (Q3 2025), and $500.0 million (Q2 2025).